A Preliminary Study Indicating Improvement in the Median Survival Time of Glioblastoma Multiforme Patients by the Application of Deuterium Depletion in Combination with Conventional Therapy

Glioblastoma multiforme (GBM) and malignant gliomas are the most common primary malignant brain tumors. Temozolomide (TMZ) chemotherapy plus radiation therapy (RT), admi-mistered after debulking surgery, increased the median survival time (MST) from 12.1 months with RT alone merely to 14.6 months, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Somlyai, Gábor, Kovács, Beáta Zsuzsanna, Papp, András, Somlyai, Ildikó
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377426/
https://www.ncbi.nlm.nih.gov/pubmed/37509628
http://dx.doi.org/10.3390/biomedicines11071989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377426/
https://www.ncbi.nlm.nih.gov/pubmed/37509628
http://dx.doi.org/10.3390/biomedicines11071989

Ejemplares similares